Goodwill Pharma has reached another important milestone. With the expansion of our GMP pharmaceutical manufacturing license, we have significantly broadened our operational capabilities and the scope of services we provide.
The new authorization covers the release, packaging, quality control, and storage of medicinal products, as well as the release and testing of imported pharmaceutical products. Through this expansion, we are now able to participate in the entire regulatory pathway for products manufactured outside the European Union entering regulated markets.
Our quality control activities are supported by our own modern laboratory. Our goal is to ensure the continuous quality of medicines and guarantee full traceability throughout the entire process.
The license extension is the result of deliberate development efforts. Targeted infrastructure investments and strengthened quality assurance systems have laid the foundation for the expanded authorization. This step goes beyond increasing operational capacity – it also represents a new level from a business perspective. We are able to offer more integrated, higher value-added services to our partners while further strengthening our position in key areas of the pharmaceutical value chain.